These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9668626)

  • 61. 5-Hydroxytryptamine(7) receptor activation decreases slow afterhyperpolarization amplitude in CA3 hippocampal pyramidal cells.
    Bacon WL; Beck SG
    J Pharmacol Exp Ther; 2000 Aug; 294(2):672-9. PubMed ID: 10900247
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The 5-HT4 receptor.
    Ford AP; Clarke DE
    Med Res Rev; 1993 Nov; 13(6):633-62. PubMed ID: 8258998
    [No Abstract]   [Full Text] [Related]  

  • 63. Morphologic consequences of serotonin neurotoxin administration: neuron-target cell interaction in the rat subcommissural organ.
    Møllgård K; Lundberg JJ; Wiklund L; Lachenmayer L; Baumgarten HG
    Ann N Y Acad Sci; 1978 Jun; 305():262-88. PubMed ID: 360936
    [No Abstract]   [Full Text] [Related]  

  • 64. Serotonin receptor subtypes and sexual behavior.
    Gorzalka BB; Mendelson SD; Watson NV
    Ann N Y Acad Sci; 1990; 600():435-44; discussion 445-6. PubMed ID: 2252325
    [No Abstract]   [Full Text] [Related]  

  • 65. [Central serotonin receptor subtypes and drug development].
    Saito H; Minami K
    Nihon Yakurigaku Zasshi; 1997 Sep; 110(3):97-9. PubMed ID: 9327412
    [No Abstract]   [Full Text] [Related]  

  • 66. 5-HT neuroendocrine responses during psychotropic drug treatment: an investigation of the effects of lithium.
    Cowen PJ; Cohen PR; McCance SL; Friston KJ
    J Neurosci Methods; 1990 Sep; 34(1-3):201-5. PubMed ID: 2259242
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Serotonin, stress and corticoids.
    Watson S; Man MS
    J Psychopharmacol; 2000; 14(4):419-21. PubMed ID: 11198063
    [No Abstract]   [Full Text] [Related]  

  • 68. Effects of serotonergic agonists on neuroendocrine responses of rhesus monkeys and patients with depression and anxiety disorders.
    Heninger GR; Charney DS; Price LH; Delgado P; Woods S; Goodman W
    Psychopharmacol Ser; 1989; 7():94-104. PubMed ID: 2687871
    [No Abstract]   [Full Text] [Related]  

  • 69. Neuroendocrine challenge tests: assessment of 5-HT function in anxiety and depression.
    Power AC; Cowen PJ
    Mol Aspects Med; 1992; 13(3):205-20. PubMed ID: 1435104
    [No Abstract]   [Full Text] [Related]  

  • 70. Recent advances in 5-hydroxytryptamine (5-HT) receptor research: how many pathophysiological roles does 5-HT play via its multiple receptor subtypes? Foreword.
    Hirafuji M
    Biol Pharm Bull; 2013; 36(9):1391. PubMed ID: 23995646
    [No Abstract]   [Full Text] [Related]  

  • 71. Neuroendocrine control of adrenocortical cells by serotonin in amphibians and mammals.
    Contesse V; Vaudry H; Lefebvre H; Hamel C; Delarue C
    Ann N Y Acad Sci; 1998 May; 839():270-4. PubMed ID: 9629164
    [No Abstract]   [Full Text] [Related]  

  • 72. Complex interactions in 5-HT motor programmes.
    Chaouloff F
    Trends Pharmacol Sci; 1994 Dec; 15(12):444-5. PubMed ID: 7886814
    [No Abstract]   [Full Text] [Related]  

  • 73. Pharmacoendocrine studies in anxiety.
    Nutt DJ
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():214A-215A. PubMed ID: 1323391
    [No Abstract]   [Full Text] [Related]  

  • 74. Animal models of serotonin behavior.
    Green AR; Backus LI
    Ann N Y Acad Sci; 1990; 600():237-48; discussion 248-9. PubMed ID: 2252312
    [No Abstract]   [Full Text] [Related]  

  • 75. Serotonin and sleep regulation.
    Holsboer F
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():349A-350A. PubMed ID: 1498866
    [No Abstract]   [Full Text] [Related]  

  • 76. Role of 5-HT in defensive behavior and anxiety.
    Graeff FG
    Rev Neurosci; 1993; 4(2):181-211. PubMed ID: 7952387
    [No Abstract]   [Full Text] [Related]  

  • 77. My personal journey with anxiety.
    Howard O
    Vet Rec; 2020 Oct; 187(9):367. PubMed ID: 33127795
    [No Abstract]   [Full Text] [Related]  

  • 78. Agonistic properties of a series of psychotropic drugs at 5-HT
    Odagaki Y; Mikami M; Kinoshita M; Meana JJ; Callado LF; García-Sevilla JA; Borroto-Escuela DO; Fuxe K
    Pharmacol Rep; 2023 Apr; 75(2):266-275. PubMed ID: 36637685
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Acute 5-HT
    Papp N; Koncz S; Kostyalik D; Kitka T; Petschner P; Vas S; Bagdy G
    Front Pharmacol; 2019; 10():1636. PubMed ID: 32063851
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Chronic escitalopram treatment caused dissociative adaptation in serotonin (5-HT) 2C receptor antagonist-induced effects in REM sleep, wake and theta wave activity.
    Kostyalik D; Kátai Z; Vas S; Pap D; Petschner P; Molnár E; Gyertyán I; Kalmár L; Tóthfalusi L; Bagdy G
    Exp Brain Res; 2014 Mar; 232(3):935-46. PubMed ID: 24395141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.